According to Pharma Mar's latest financial reports and stock price the company's current Operating Margin is 8.26%. At the end of 2024 the company had an Operating Margin of 6.85%.
Year | Operating Margin | Change |
---|---|---|
2024 | 6.85% | -399.21% |
2023 | -2.29% | -110.27% |
2022 | 22.30% | -46.12% |
2021 | 41.39% | -23.26% |
2020 | 53.94% | -313.76% |
2019 | -25.23% | 37.32% |
2018 | -18.37% | 18.16% |
2017 | -15.55% | 13.93% |
2016 | -13.65% | -545.41% |
2015 | 3.06% | -63.16% |
2014 | 8.32% | -15.32% |
2013 | 9.82% | 42.11% |
2012 | 6.91% | -41.33% |
2011 | 11.78% | -224.31% |
2010 | -9.48% | -55.39% |
2009 | -21.25% | -47.97% |
2008 | -40.84% | -25.72% |
2007 | -54.99% | -13.82% |
2006 | -63.81% | 16.36% |
2005 | -54.84% | -82.02% |
2004 | -304.93% | 744.04% |
2003 | -36.13% | -45.44% |
2002 | -66.21% |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.